KR101930342B1 - A cosmetic composition - Google Patents

A cosmetic composition Download PDF

Info

Publication number
KR101930342B1
KR101930342B1 KR1020180113419A KR20180113419A KR101930342B1 KR 101930342 B1 KR101930342 B1 KR 101930342B1 KR 1020180113419 A KR1020180113419 A KR 1020180113419A KR 20180113419 A KR20180113419 A KR 20180113419A KR 101930342 B1 KR101930342 B1 KR 101930342B1
Authority
KR
South Korea
Prior art keywords
culture
weight
strain
skin
lactobacillus
Prior art date
Application number
KR1020180113419A
Other languages
Korean (ko)
Inventor
이재섭
배준태
김석종
김윤석
박지영
Original Assignee
주식회사 제이투케이바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제이투케이바이오 filed Critical 주식회사 제이투케이바이오
Priority to KR1020180113419A priority Critical patent/KR101930342B1/en
Application granted granted Critical
Publication of KR101930342B1 publication Critical patent/KR101930342B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • C12R1/225
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Abstract

The present invention relates to a composition for external application for skin comprising a novel Lactobacillus curvatus (Accession number: KCTC 13494BP) J2K-01 strain isolated from aged kimchi in Jeju area, a crushed product of the strain, a culture or extract of the strain as an active ingredient. The composition exhibits excellent effects on skin condition improvement such as antioxidant effects, collagen synthesis promotion effects, skin wrinkle amelioration effects, skin elasticity enhancement effects and the like.

Description

피부 탄력 및 주름개선용 화장료 조성물{A COSMETIC COMPOSITION}A cosmetic composition for improving skin elasticity and wrinkles {A COSMETIC COMPOSITION}

본 발명은 피부 탄력 및 주름개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin elasticity and wrinkles.

자외선에 의한 피부는 활성산소종을 생성시켜 피부암, 광독성, 자기면역장애, 광과민증과 피부노화 등을 유발하게 된다(Cadenas, Ann. Rev. Biochem., 58:79, 1989). Skin caused by ultraviolet rays generates reactive oxygen species, which causes skin cancer, phototoxicity, autoimmune disorders, photosensitivity and skin aging (Cadenas, Ann. Rev. Biochem., 58:79, 1989).

생체 내에서 콜라겐과 같은 세포외기질의 합성과 분해는 적절하게 조절되나, 노화가 진행되면서 그 합성이 점차 감소하며 콜라겐을 분해하는 효소인 기질 금속단백질 분해효소(MMP)의 발현이 촉진되어 피부의 탄력이 저하되고 주름이 형성된다.Synthesis and degradation of collagen-like extracellular matrix in vivo are appropriately controlled, but as the aging progresses, the synthesis gradually decreases and the expression of matrix metalloproteinase (MMP), an enzyme that degrades collagen, is promoted, And wrinkles are formed.

또한 이러한 MMP는 자외선 조사에 의해 활성화되기도 한다. These MMPs are also activated by ultraviolet irradiation.

그러므로 세포내에서 활성화가 유도되는 MMP 발현을 조절하거나 그 활성을 억제할 수 있는 물질의 개발이 요구되고 있다.Therefore, it is required to develop a substance capable of controlling the activation of MMP expression in cells or inhibiting its activity.

김치(Kimchi)는 대표적인 전통 발효 식품으로서 다양한 기능의 항산화, 항노화, 항비만, 항염, 항균, 항알러지, 면역증진효과 등이 알려져 있다. Kimchi is a typical traditional fermented food, and various functional antioxidants, anti-aging, anti-obesity, anti-inflammatory, antibacterial, anti-allergic and immunity enhancing effects are known.

이러한 김치의 생체 내 효능효과는 영양성분과 발효 유산균의 대사산물에서 유래된다. 김치 유산균은 주로 락토바실러스(Lactobacillus sp.), 류코노스톡(Leuconostoc sp.), 페디코커스(Pediococcus sp.) 등이 김치의 발효와 영양분 생성에 관여하며, 김치에서 분리한 유산균을 활용하여 다양한 프로바이오틱스(Probiotics)의 건강기능식품이 출시되고 있다. The in vivo efficacy of kimchi is derived from the nutritional components and metabolites of fermented lactic acid bacteria. Lactobacillus sp., Leuconostoc sp. And Pediococcus sp. Are involved in the fermentation and nutrient production of kimchi, and lactic acid bacteria isolated from kimchi are used for various probiotics (Probiotics) health food products are being released.

프로바이오틱스란 살아있는 상태로 체내에 들어가서 면역 및 다양한 기능성을 주어 건강에 도움을 주는 유익한 미생물을 말한다. Probiotics is a beneficial microorganism that enters the body in a living state and gives immunity and various functions to help health.

대부분 프로바이오틱스는 주로 유산균 종류이며 육류, 채소, 우유, 치즈, 요구르트 등의 다양한 발효식품에 사용되어 왔다. Most probiotics are lactic acid bacteria and have been used in a variety of fermented foods such as meat, vegetables, milk, cheese, and yogurt.

프로바이오틱스로 인정받기 위해서는 균주가 체내의 위산과 담즙산에서 생존해 소장까지 도달하여야 하며 장 상피세포에 부착하여 생장할 수 있어야 한다. To be recognized as a probiotic, the strain must survive in the body's stomach and bile acid to reach the small intestine and attach to the epithelial cells to grow.

또한 독성이 없고 비병원성이어야 하며 장관 내에서 항균, 항염, 항암, 항산화 등의 유용한 효과를 나타내는 것이 바람직하다.It should also be non-toxic and non-pathogenic, and exhibit beneficial effects such as antibacterial, anti-inflammatory, anti-cancer and antioxidant properties in the intestinal tract.

관련 선행 특허로, 한국공개특허 제10-2018-0046831호(특허문헌 1)에 피부장벽 회복 및 피부노화 개선 능이 있는 화장료용 유산균 배양액에 관한 기술이 개시되어 있으며, 한국공개특허 제10-2018-0064185호(특허문헌 2)에 미강발효 추출물 주성분으로 하는 발효액 제조방법 및 화장료 조성물에 관한 기술이 개시되어 있다.As a related prior patent, Korean Patent Laid-Open No. 10-2018-0046831 (Patent Document 1) discloses a technique for culturing a lactic acid bacterium for cosmetic use having skin barrier recovery and skin aging-improving ability, Korean Patent Laid- 0064185 (Patent Document 2) discloses a method for producing a fermentation broth as a main component of rice germinated fermented extract and a technique relating to a cosmetic composition.

KR 10-2018-0046831 (2018.05.09)KR 10-2018-0046831 (2018.05.09) KR 10-2018-0064185 (2018.06.14)KR 10-2018-0064185 (2018.06.14)

본 발명은 상기와 같은 문제점을 해결하고자하는 것으로 그 목적은, 락토바실러스 쿠르바투스(Lactobacillus curvatus) J2K-01(기탁번호: KCTC 13494BP)의 신규한 균주를 제공하는 것이다.The object of the present invention is to provide a novel strain of Lactobacillus curvatus J2K-01 (accession number: KCTC 13494BP).

본 발명의 다른 목적은 신규한 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP)을 유효성분으로 함유하는 조성물을 이용하여 피부의 주름개선, 탄력개선용 화장료 조성물을 제공하는 것이다.Another object of the present invention is to provide a cosmetic composition for improving the wrinkles and elasticity of skin by using a composition containing a novel Lactobacillus carbatis J2K-01 (accession number: KCTC 13494BP) as an active ingredient.

상기와 같은 과제를 해결하기 위하여 본 발명은 묵은 김치로부터 유래한 신규한 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주를 제공한다.In order to solve the above-mentioned problems, the present invention provides a novel strain of Lactobacillus Carbatus J2K-01 (accession number: KCTC 13494BP) derived from an old Kimchi.

본 발명에 있어서, 상기 균주는 서열번호 1의 16S rRNA 서열을 가지는 것이 바람직하나 이에 한정되지 아니한다.In the present invention, the strain preferably has the 16S rRNA sequence of SEQ ID NO: 1, but is not limited thereto.

또, 본 발명의 배양물은, 상기 균주를 배지에 접종하여 배양하여 제조하되, 배양액의 pH를 5.0 내지 6.0으로 조정하고, 배양 시간은 12시간 내지 48시간, 배양 온도는 27 내지 37℃로 하며, 배양 배지의 탄소원으로서 글루코스를 배지 총부피 대비 0.5 내지 3%(W/V) 포함시키고, 배양 배지의 질소원으로서 효모추출물을 배지 총부피 대비 0.5 내지 2%(W/V) 포함시키며, 배양 배지의 미량원소원으로서 황산망간을 배지 총부피 대비 0.05 내지 0.1%(W/V), 포함시키고, 황산마그네슘을 배지 총부피 대비 0.02 내지 0.05%(W/V) 포함시키며, 염화칼슘을 배지 총부피 대비 0.02 내지 0.05%(W/V) 포함시키는 조건으로 배양한 것을 특징으로 한다.The culture of the present invention is prepared by inoculating and cultivating the above-mentioned strain into a culture medium, wherein the pH of the culture medium is adjusted to 5.0 to 6.0, the culture time is 12 to 48 hours, the culture temperature is 27 to 37 DEG C , 0.5 to 3% (W / V) of glucose as the carbon source of the culture medium, 0.5 to 2% (W / V) of the yeast extract as the nitrogen source of the culture medium, Manganese sulfate is contained in an amount of 0.05 to 0.1% (W / V) relative to the total volume of the medium, magnesium sulfate is contained in an amount of 0.02 to 0.05% (W / V) relative to the total volume of the medium, 0.02 to 0.05% (W / V).

본 발명의 화장료 조성물은 상기 균주, 그 균주의 파쇄물, 그 균주의 배양액 또는 그 추출물로 이루어지는 군에서 선택된 1종 이상을 유효성분으로 한다.The cosmetic composition of the present invention contains, as an active ingredient, at least one member selected from the group consisting of the above strain, a lysate of the strain, a culture solution of the strain or an extract thereof.

이때, 상기 유효성분은 화장료 조성물 전체에 대해 0.001 ~ 30.0 중량% 함유되는 것을 특징으로 한다.In this case, the active ingredient is contained in an amount of 0.001 to 30.0% by weight based on the total amount of the cosmetic composition.

또, 본 발명의 피부 탄력 및 주름개선용 조성물은 상기 화장료 조성물을 유효성분으로 포함한다.The composition for improving skin elasticity and wrinkles of the present invention contains the cosmetic composition as an active ingredient.

삭제delete

본 발명을 통하여 알 수 있는 것과 같이, 본 발명의 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주, 그 균주의 파쇄물, 그 균주의 배양액 또는 추출물을 유효성분으로 포함하는 조성물은, 피부 흡수력이 뛰어나고, 피부자극이 없으면서도 기존의 단순 추출물 보다 활성산소 소거효과와 MMP 저해효과와 자외선 조사에 의한 MMP 발현 조절 효과 등 우수한 항노화 효과를 나타내었다.As can be seen from the present invention, the composition comprising the Lactobacillus Carbatus J2K-01 (accession number: KCTC 13494BP) strain of the present invention, the lysate of the strain, the culture solution or the extract of the strain as an active ingredient, It showed excellent antioxidant effect such as active oxygen scavenging effect, MMP inhibitory effect and UV irradiation - induced MMP expression control effect than conventional simple extract even without skin irritation.

또한, 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주의 배양물을 함유하는 화장수, 크림, 유액, 팩, 파우더 등의 화장료 조성물은 활성산소 소거효과와 콜라겐 분해효소 활성 조절효과, 피부 잔주름 개선 효과, 피부 탄력 개선 효과를 나타낸다. In addition, cosmetic compositions such as lotion, cream, lotion, pack, and powder containing a culture of Lactobacillus carbatus J2K-01 (Accession No .: KCTC 13494BP) strain have an active oxygen scavenging effect and a collagenase activity modulating effect, Skin wrinkles, and skin elasticity.

도 1은 본 발명 락토바실러스 쿠르바투스(Lactobacillus curvatus) J2K-01(기탁번호: KCTC 13494BP)의 동정 결과 16S rRNA 서열도(actobacillus curvatus J2K-01, 16S rRNA gene complete cds, 1521bp)이다.
도 2는 본 발명 락토바실러스 쿠르바투스(Lactobacillus curvatus) J2K-01(기탁번호: KCTC 13494BP) 균주의 동정 결과를 나타낸 균주 계통도(Phylogenetic tree of Lactobacillus curvatus J2K-01)이다.
도 3은 본 발명 락토바실러스 쿠르바토스 J2K-01 균주의 기탁증이다.
1 is a 16S rRNA sequence diagram (actobacillus curvatus J2K-01, 16S rRNA gene complete cds, 1521 bp) as a result of identification of Lactobacillus curvatus J2K-01 (accession number: KCTC 13494BP).
Fig. 2 is a phylogenetic tree of Lactobacillus curvatus J2K-01 showing the result of identification of the strain Lactobacillus curvatus J2K-01 (accession number: KCTC 13494BP).
Fig. 3 is a donation of the Lactobacillus carbatoth J2K-01 strain of the present invention.

이하 본 발명을 설명한다.Hereinafter, the present invention will be described.

본 발명자들은 인체에 유용한 미생물을 탐색하는 과정에서 피부에 안전하고 효능이 우수하며 화장품 안전성에 영향을 미치지 않는 화장품 원료를 개발하고자, 제주지역 묵은 김치로부터 다수의 신규한 락토바실러스(Lactobacillus sp.) 균주를 분리 동정하게 되었다.In order to develop a cosmetic raw material that is safe for skin, excellent in efficacy and has no effect on cosmetic safety in searching for microorganisms useful for human body, the present inventors have found that a large number of new Lactobacillus sp. .

또한 상기 균주에서 배양한 배양물에서 유효성분의 함량증가를 확인하고, 이 배양물이 피부자극을 유발하지 않으면서 화장료 조성물로 탁월한 효과를 갖는 락토바실러스 쿠르바투스(Lacotobacillus curvatus) 균주를 확인하고, 이를 2018년 03월 14일자로 한국생명공학연구원 생물자원센터(Korean Collection for Type Culture, KCTC)에 락토바실러스 쿠르바투스(Lacotobacillus curvatus) J2K-01을 기탁함으로써 본 발명을 완성하였다(기탁번호: KCTC 13494BP).Also, it was confirmed that the content of the active ingredient was increased in the culture cultured in the above strain, and Lacobacillus curvatus strain having an excellent effect as a cosmetic composition was confirmed without causing skin irritation, it to March 14, 2018 South Korea Lactobacillus Pico Yerba biotechnology Research Institute biological resource Center (Korean Collection for Type Culture, KCTC ) Tooth (Lacotobacillus curvatus J2K-01 (Accession No .: KCTC 13494BP).

본 발명에 따른 배양 방법은 락토바실러스 쿠르바투스(Lactobacillus curvatus) J2K-01(기탁번호: KCTC 13494BP)를 배양하는 단계; 상기의 배양 후, 원심분리하여 배양액으로부터 균체를 제거하고 상등액을 회수하는 단계; 상기에서 회수한 상등액을 여과하여 균체를 제거하는 단계;를 통해 수득한 배양물 또는 상기에서 회수한 균체를 파쇄하여 추출한 추출물을 여과하여 균체를 제거한 추출물을 유효성분으로 함유하는 것을 특징으로 하는 조성물을 제공한다.The culture method according to the present invention comprises culturing Lactobacillus curvatus J2K-01 (accession number: KCTC 13494BP); After the above cultivation, centrifugal separation is performed to remove the cells from the culture solution, and the supernatant is recovered; A method for producing a composition comprising the step of filtering a supernatant recovered in the above step to remove a microbial cell or a microbial cell obtained from the culture or the microbial cell recovered by the above step is filtered to remove the microbial cells, to provide.

본 발명에서 최종적으로 얻은 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주, 그 균주의 파쇄물, 그 균주의 배양액 또는 추출물은 화장료 조성물 전체에 대해 0.001~30.0중량% 함유되는 것이 바람직한데, 0.001중량% 미만으로 포함되는 경우에는 피부개선효과가 미미하고, 30.0중량%를 초과하는 경우에는 재료 투입량 대비 효율성이 떨어져 경제적이지 못하기 때문이다.The Lactobacillus carbatis J2K-01 (accession number: KCTC 13494BP) strain, the disruption product of the strain, and the culture or extract of the strain finally obtained in the present invention are preferably contained in an amount of 0.001 to 30.0% by weight based on the total cosmetic composition If the content is less than 0.001% by weight, the effect of improving the skin is insignificant. If the content is more than 30.0% by weight, the efficiency with respect to the amount of the material is poor, which is not economical.

본 발명에서 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주의 배양은 바람직하게는 배양액의 pH를 5.0 내지 6.0으로 조정하고, 최적 배양 시간은 12시간 내지 48시간, 최적 배양 온도는 27 내지 37℃, 배양 배지의 최적 탄소원으로서 글루코스를 배지 총부피 대비 0.5 내지 3%(W/V) 포함, 배양 배지의 최적 질소원으로서 효모추출물을 배지 총부피 대비 0.5 내지 2%(W/V) 포함, 및 배양 배지의 최적 미량원소원으로서 황산망간을 배지 총부피 대비 0.05 내지 0.1%(W/V), 황산마그네슘을 배지 총부피 대비 0.02 내지 0.05%(W/V), 염화칼슘을 배지 총부피 대비 0.02 내지 0.05%(W/V) 포함하는 것을 특징으로 한다.In the present invention, the culture of Lactobacillus carbatis J2K-01 (accession number: KCTC 13494BP) is preferably carried out by adjusting the pH of the culture medium to 5.0 to 6.0, optimally culturing for 12 to 48 hours, (W / V) relative to the total volume of the culture medium as the optimum carbon source of the culture medium at 27 to 37 캜, and the yeast extract as an optimal nitrogen source of the culture medium containing 0.5 to 3% (W / V) Manganese sulfate as an optimal trace element source of the culture medium, 0.05 to 0.1% (W / V) of the total volume of the medium, 0.02 to 0.05% (W / V) of the magnesium sulfate to the total volume of the medium, (W / V) relative to 0.02 to 0.05%.

한편, 본 발명에서 "유효성분으로 포함된다"는 의미는 본 발명의 조성물로부터 피부 상태의 개선 효과를 나타낼 수 있는 정도로 조성물에 배양물 여과액이 첨가되는 것을 의미하고, 성분 전달 및 안정화 등을 위하여 다양한 성분을 부성분으로 첨가하여 다양한 형태로 제형화하는 것을 포함하는 의미이다.In the present invention, the term "included as an active ingredient" means that the culture filtrate is added to the composition to such an extent as to exhibit an improvement effect on the skin condition from the composition of the present invention. It is meant to include formulating various components by adding various components as subcomponents.

또한, 본 발명은 화장료의 유효성분으로 함유하는 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 균주, 그 균주의 파쇄물, 그 균주의 배양액 또는 추출물이 항산화 효과, 콜라겐 합성 촉진효과, 피부 잔주름 개선효과, 피부 탄력 개선 효과 및 수분 흡습성이 우수한 것을 특징으로 한다.In addition, the present invention relates to a pharmaceutical composition comprising a lactobacillus carvatus J2K-01 (accession number: KCTC 13494BP) strain containing as an active ingredient of a cosmetic, a lysate thereof, a culture or extract of the strain, An effect of improving fine wrinkles, an effect of improving skin elasticity, and an excellent water hygroscopicity.

또한, 본 발명은 상기 화장료 조성물이 샴푸, 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초 화장료 제형; 수중유형 또는 유중수형의 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이새도, 치크칼라 및 아이브로우 펜슬류 중에서 선택된 화장료 조성물임을 특징으로 한다.The present invention also relates to a cosmetic composition in which the cosmetic composition is in the form of a shampoo, a lotion, a gel, a water-soluble liquid, a cream, an essence, an oil-in-water (O / W) type and a water-in-oil (W / O) type; Wherein the composition is a cosmetic composition selected from the group consisting of a makeup base, a foundation, a skin cover, a lipstick, a lip gloss, a face powder, a two-way cake, an eye shadow, a cheek color and an eyebrow pencil.

본 발명에서 조성물이란 바람직하게는 피부외용제 조성물을 의미하고, 피부외용제 조성물이란 일반적으로 피부에 적용되는 조성물 전부를 의미하고, 의약품,의약부외품, 화장료 등을 포함하는 것이다.In the present invention, the composition preferably refers to a composition for external application for skin, and the composition for external application for skin refers generally to all the compositions applied to the skin, and includes medicines, quasi drugs, and cosmetics.

본 발명의 균주의 유효성분의 피부외용제에 대한 배합량은 조성물 총량을 기준으로 0.0001∼10% 로 하는 것이 바람직하고, 보다 바람직하게는 0.01∼1% 이다.The blending amount of the effective ingredient of the strain of the present invention in the external preparation for skin is preferably 0.0001 to 10%, more preferably 0.01 to 1%, based on the total amount of the composition.

이하, 실시예를 통해 본 발명을 좀 더 구체적으로 설명한다. 단, 이들 실시예는 본 발명의 예시적인 기재일 뿐이며, 본 발명의 범위가 이들 실시예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail by way of examples. It should be noted, however, that these examples are only illustrative examples of the present invention, and the scope of the present invention is not limited to these examples.

<김치로부터 균주의 분리><Separation of strain from kimchi>

제주도산 묵은 김치를 유산균 분리 김치 시료로 사용하였다. Kimchi from Jeju Island was used as a lactic acid bacteria isolated kimchi.

상기 김치 시료들은 각각 멸균 생리식염수에 현탁 및 희석하고, 이를 0.1 mL씩 취해 디프코 락토바실리 MRS 아가 (Difco Lactobacili MRS Agar) 배지에 도말하였다.Each of the kimchi samples was suspended and diluted in sterilized physiological saline, and 0.1 mL of each of the samples was plated on a Difco Lactobacili MRS Agar medium.

이 후, 플레이트를 35℃의 항온배양기에서 2일 동안 배양하였다. Thereafter, the plate was incubated in a constant temperature incubator at 35 DEG C for 2 days.

생성된 각각의 콜로니를 MRS 아가 플레이트에 획선 접종하였고, 35℃에서 2일 동안 배양하여 백색 집락을 보이는 콜로니를 취했다.Each of the resulting colonies was inoculated on MRS agar plates and cultured at 35 DEG C for 2 days to obtain a colonies showing white colonies.

위와 같은 방법으로 락토바실러스 쿠르바투스 J2K-01을 김치로부터 분리하였다.Lactobacillus carvatus J2K-01 was isolated from kimchi in the same manner as above.

<락토바실러스 쿠르바투스 J2K-01 배양물 제조>&Lt; Preparation of Lactobacillus carbatus J2K-01 culture >

실시예 1로부터 순수 분리한 락토바실러스 쿠르바투스 J2K-01 균주의 종균배양(seed culture)은 MRS 배지에 단일 콜로니를 접종하여 35℃ 항온배양기에 24시간 동안 배양하여 사용하였다.A seed culture of the Lactobacillus carbatis J2K-01 strain isolated pure from Example 1 was carried out by inoculating a single colony into MRS medium and incubating in a constant temperature incubator at 35 ° C for 24 hours.

락토바실러스 쿠르바투스 J2K-01 균주의 성장이 최적화된 배지조성은 글루코스 2%, 효모추출물 1%, 황산망간 0.1%, 황산마그네슘 0.05%, 염화칼슘 0.025%를 함유한 최적화된 배지로 하며 pH 5.5로 조정한 배지에 상기 종균배양액을 1%(V/V)되게 접종한 후, 온도 35℃, 회전수 120rpm 조건으로 24시간 배양하였다. The optimized culture medium of Lactobacillus carbbatus J2K-01 strain was optimized medium containing 2% of glucose, 1% of yeast extract, 0.1% of manganese sulfate, 0.05% of magnesium sulfate and 0.025% of calcium chloride and pH 5.5 The seed culture was inoculated to the conditioned medium in a concentration of 1% (V / V), and then cultured at a temperature of 35 ° C and a rotation speed of 120 rpm for 24 hours.

배양 후 원심분리하여 배양액으로부터 균체를 제거하고 상등액을 여과하여 균체를 완전히 제거한 락토바실러스 쿠르바투스 J2K-01 배양물을 수득하였다.After culturing, the cells were removed from the culture by centrifugation, and the supernatant was filtered to obtain a Lactobacillus carbamazep J2K-01 culture in which the cells were completely removed.

실험예 1 : 자유라디칼 소거활성 측정 실험Experimental Example 1: Measurement of free radical scavenging activity

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 자유라디칼 소거활성을 측정하기 위해 실험실 조건에서 녹차추출물 같은 우수한 항산화활성을 갖는 추출물을 비교샘플로 하고 DPPH법을 이용하여 자유라디칼 소거 활성을 측정하였다.To determine the free radical scavenging activity of the culture of the Lactobacillus carbatis J2K-01 strain obtained in Example 2, extracts having excellent antioxidative activity, such as green tea extract under laboratory conditions, were used as comparative samples and free The radical scavenging activity was measured.

DPPH법은 DPPH(2,2-Di(4-tert-octylphenyl)-1-1picrylhydrazyl free radical)라는 유리기를 사용하여 환원력에 의한 자유라디칼 소거활성을 측정하였다.The DPPH method used free radical scavenging activity by reducing power using a free radical called DPPH (2,2-Di (4-tert-octylphenyl) -1-1picrylhydrazyl free radical).

피검물질에 의해 DPPH가 환원되어 흡광도가 감소하는 정도를 공시험액의 흡광도와 비교하여 파장 560nm에서 자유라디칼 소거율을 측정하였다.Free radical scavenging was measured at a wavelength of 560 nm by comparing the degree of reduction of the absorbance by DPPH reduction by the test substance with the absorbance of the blank test solution.

DPPH 자유라디칼 소거활성 측정을 위하여 0.2%, 0.1%, 0.05%, 0.005% 농도의 배양물을 준비하였다. For the measurement of DPPH free radical scavenging activity, cultures were prepared at concentrations of 0.2%, 0.1%, 0.05% and 0.005%.

상기 농도의 배양물을 96웰 플레이트에 각각 넣고, 여기에 100uM 메탄올용액으로 제조된 DPPH를 첨가하여 용액의 총 부피가 200㎕가 되도록 하였다. The culture at the above concentration was placed in a 96-well plate, and DPPH prepared from 100 uM methanol solution was added thereto to make the total volume of the solution 200 μl.

이것을 37℃에서 30분간 방치한 후 560nm에서 흡광도를 측정하였다.After incubation at 37 ° C for 30 minutes, absorbance was measured at 560 nm.

<수학식 1>&Quot; (1) &quot;

자유라디칼 소거활성(%)= {100-(B/A)}X100Free radical scavenging activity (%) = {100- (B / A)} X100

A: 본 발명의 시료를 처리하지 않은 대조군 웰의 흡광도,A: Absorbance of the control well without treatment of the sample of the present invention,

B: 본 발명의 시료를 처리한 실험군 웰의 흡광도,B: absorbance of the experimental group well treated with the sample of the present invention,

표 1와 같이, 실시예 2의 락토바실러스 쿠르바투스 J2K-01 균주의 배양물은 항산화 활성이 우수한 녹차추출물보다 더 우수한 항산화 효과를 나타냄을 알 수 있다.As shown in Table 1, the culture of the Lactobacillus carbamazep J2K-01 strain of Example 2 shows an antioxidative effect superior to that of the green tea extract having excellent antioxidative activity.

시료명Name of sample 항산화효과(%)Antioxidative effect(%) 실시예 2 (0.05중량%)Example 2 (0.05% by weight) 8585 실시예 2 (0.1중량%)Example 2 (0.1% by weight) 9292 실시예 2 (0.2중량%)Example 2 (0.2% by weight) 9898 녹차 추출물 (0.2중량%)Green tea extract (0.2% by weight) 9090

실험예 2: 시료의 세포독성Experimental Example 2: Cytotoxicity of a sample

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 피부세포에 대한 세포독성을 평가하였다.The cytotoxicity of the cultured product of Lactobacillus carbatis J2K-01 strain obtained in Example 2 on skin cells was evaluated.

96-웰 시험 플레이트에 세포배양 배지(DMEM에 10% FBS가 첨가된 것)에 희석된 섬유아세포(fibroblast)를 1 x 105 cells/mL개씩 넣고 24시간 동안 부착시켰다.To the 96-well test plate, 1 x 10 5 cells / mL of diluted fibroblast was added to the cell culture medium (DMEM supplemented with 10% FBS) and adhered for 24 hours.

실시예 2에서 수득한 시료를 각 웰에 적절한 농도로 희석하여 처리한 후 24시간 동안 배양하였다. The sample obtained in Example 2 was diluted to an appropriate concentration in each well and treated for 24 hours.

24시간이 지나면 배지를 제거하고, 각 웰 당 MTT(3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide) 용액(2.5 mg/㎖)이 함유된 세포배양 배지 200 uL를 넣은 후 2시간 동안 37℃ CO2배양기에서 배양하였다.After 24 hours, the medium was removed, and 200 μL of cell culture medium containing MTT (3- (4,5-dimethylthiazol-2yl) -2,5-diphenyl tetrazolium bromide) solution (2.5 mg / And then cultured in a 37 ° C CO 2 incubator for 2 hours.

배지를 제거하고 DMSO(Dimethyl sulfoxide)를 100 uL씩 넣어주었다. The medium was removed and 100 μL of DMSO (dimethyl sulfoxide) was added.

5분간 진탕하여 세포를 용해시킨 후 마이크로플레이트 판독기에서 565 nm 흡광도를 측정하였다. 수학시 2와 같이 세포생존율(%)을 정하였으며, 세포의 생존에 영향을 미치지 않는 시료의 농도를 결정하였다.Cells were lysed by shaking for 5 minutes and absorbance at 565 nm was measured in a microplate reader. The cell viability (%) was determined as in the mathematics 2 and the concentration of the sample that did not affect cell survival was determined.

<수학식 2>&Quot; (2) &quot;

세포생존율(%)={(St-Bo)/(Bt-Bo)}X 100Cell survival rate (%) = {(St-Bo) / (Bt-Bo)} X 100

Bo: 세포배양배지만을 발색 반응한 웰의 565 nm 흡광값,Bo: 565 nm absorbance value of wells reacting with cell culture medium,

Bt: 시료를 처리하지 않고 발색 반응한 웰의 565 nm 흡광값,Bt: 565 nm absorbance value of a well color-reacted without sample treatment,

St: 시료를 처리하고 발색 반응한 웰의 565 nm 흡광값.St: 565 nm absorbance of the well treated and chromogenic.

시료명Name of sample 100% 세포 생존 농도100% cell viability concentration 실시예 2 Example 2 5%5% 실시예 2 Example 2 3%3% 실시예 2 Example 2 1%One% 실시예 2 Example 2 0.5%0.5%

상기 표 2와 같이, 피부 섬유아세포의 100% 생존 처리농도는 실시예 2의 락토바실러스 쿠르바투스 J2K-01 균주의 배양물이 5% 이하로, 이는 일반적으로 화장품에 사용되는 농도를 고려하였을 때 피부 자극 유발 가능성이 적은 안전한 시료인 것을 말해준다.As shown in Table 2, the 100% survival treatment concentration of the dermal fibroblasts was 5% or less in the culture of the Lactobacillus carbamazep J2K-01 strain of Example 2, It is a safe sample with less possibility of skin irritation.

실험예 3 : 인 비트로 MMP-1 활성저해 실험Experimental Example 3: Inhibitory activity of MMP-1 in vitro

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 MMP-1 활성 저해 효과를 측정하기 위하여 형광 분석법을 이용하였다.Fluorescence analysis was used to measure the inhibitory effect of MMP-1 activity of the culture of the Lactobacillus coumarbatus J2K-01 strain obtained in Example 2 above.

실험에 사용한 기질은 형광물질이 표지된 DQ-Collagen이고, 효소(collagenase)는 Molecular probe사(Eugene, OR, USA)에서 시판중인 제품을 사용하였으며, 반응완충액(0.5 M Tris-HCl, 1.5 M NaCl, 50 mM CaCl2, 2 mM sodium azide, pH 7.6)은 10배 희석 후 사용하였다. The substrate used was DQ-Collagen labeled with fluorescein and the collagenase was purchased from Molecular probe (Eugene, OR, USA) and incubated in reaction buffer (0.5 M Tris-HCl, 1.5 M NaCl , 50 mM CaCl2, 2 mM sodium azide, pH 7.6) was used after 10-fold dilution.

반응완충액 100㎕에 0.25㎎/㎖로 반응완충액에 용해한 DQ collagen 20㎕와 실시예 2에서 수득한 시료를 0.2%, 0.1%, 0.05% 농도의 배양물을 준비하여 각각 40㎕을 첨가하고 0.5unit로 희석한 콜라게나아제(collagenase) 40㎕을 첨가하였다.20 μl of DQ collagen dissolved in a reaction buffer at 0.25 mg / ml in the reaction buffer and 40 μl each of 0.2%, 0.1%, and 0.05% concentrations of the sample obtained in Example 2 were added, and 0.5 μl And 40 [mu] l of diluted collagenase.

어두운 곳, 실온에서 20분 경과 후 형광 분광광도계(Perkin Elmer, UK)를 이용하여 흡수파장 495nm, 방출파장 515nm로 형광값을 측정하고, 대조군으로서 효소액 대신 반응완충액을 효소와 동량 첨가하여 형광값을 측정하였으며 시료 자체의 형광값도 측정하여 효소활성 계산시 보정하였다.After 20 minutes at room temperature in a dark place, the fluorescence value was measured using a fluorescence spectrophotometer (Perkin Elmer, UK) with an absorption wavelength of 495 nm and an emission wavelength of 515 nm. As a control, a fluorescence value The fluorescence value of the sample itself was also measured and corrected for the enzyme activity.

결과는 표 3에 나타냈으며 실시예 2의 시료를 0.2% 처리 시 금속단백질분해효소(MMP-1) 저해 활성이 우수하였으며, 녹차 추출물에 비해서도 저해 활성이 우수하였다.The results are shown in Table 3. The metal protease (MMP-1) inhibitory activity was excellent at 0.2% treatment of the sample of Example 2, and the inhibitory activity was better than that of green tea extract.

상기 결과로부터 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 금속단백질분해효소(MMP-1) 활성 저해효과가 우수하다는 사실을 확인할 수 있었고, 이를 바탕으로 본 발명의 피부 외용제 조성물은 금속단백질분해효소를 효과적으로 저해함으로써 피부의 탄력 저하 및 주름 형성을 예방 또는 개선할 수 있음을 추론할 수 있었다.From the above results, it was confirmed that the effect of inhibiting metalloproteinase (MMP-1) activity of the culture of Lactobacillus carbapthus J2K-01 strain was excellent. Based on this fact, the skin external- It is possible to infer that the elasticity of the skin and the formation of wrinkles can be prevented or improved.

시료명Name of sample MMP-1 활성 저해율 (%)MMP-1 activity inhibition rate (%) 실시예 2 (0.05중량%)Example 2 (0.05% by weight) 3838 실시예 2 (0.1중량%)Example 2 (0.1% by weight) 5252 실시예 2 (0.2중량%)Example 2 (0.2% by weight) 7474 녹차추출물 (0.2중량%)Green tea extract (0.2% by weight) 6767

실험예 4 : 자외선 조사 후 MMP-1 발현억제 평가Experimental Example 4: Evaluation of inhibition of MMP-1 expression after UV irradiation

UV 조사 후 상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 첨가 후 MMP-1 농도를 측정하기 위해서 효소면역 시험법(ELISA)을 실시하였다.Enzyme immunoassay (ELISA) was performed to measure the concentration of MMP-1 after addition of the culture of Lactobacillus carbamazu strain J2K-01 obtained in Example 2 after UV irradiation.

UV 챔버를 이용하여 인간 진피 섬유아세포에서 UVA를 6.3J/㎠의 에너지로 조사하였다. UVA was irradiated in human dermal fibroblasts at an energy of 6.3 J / cm &lt; 2 &gt; using a UV chamber.

자외선 조사량과 배양시간은 예비실험을 통하여 섬유아세포에서 MMP 발현량이 최대가 되는 조건을 확립하였다. Ultraviolet irradiation dose and incubation time were established by preliminary experiment to maximize MMP expression level in fibroblasts.

음성 대조군은 은박지로 싸서 UVA의 환경에 같은 전사되는 동안의 세포는 이전에 분주된 배지 그대로이고 UVA를 조사한 후 샘플이 들어간 배지로 교환하여 24시간 배양 후 배지를 회수하여 96웰에 코팅하였다. 일차항체(MMP-1 (Ab-5) 단일클론항체)를 처리하고 37℃에서 60분간 반응시켰다. The negative control was wrapped in a silver foil and the cells in the UVA environment were transferred to the medium containing the sample after irradiated with UVA, and cultured for 24 hours. Then, the medium was recovered and coated on 96 wells. The primary antibody (MMP-1 (Ab-5) monoclonal antibody) was treated and reacted at 37 ° C for 60 minutes.

이차항체인 항마우스 IgG(whole mouse, alkaline phosphatase conjugated)를 가하여 다시 60분 정도 반응시킨 후, 알카린 포스파타제 기질용액(1㎎/㎖ p-나이트로페닐인산을 포함하는 다이에탄올아민 완충용액)을 상온에서 30분간 반응시키고 마이크로플레이트 판독기로 405nm 흡광도를 측정하였다. 대조군으로는 시료를 첨가하지 않은 것을 사용하였다.The cells were incubated with a secondary antibody, anti-mouse IgG (alkaline phosphatase conjugated), for 60 minutes, and incubated with an alkaline phosphatase substrate solution (diethanolamine buffer solution containing 1 mg / ml p- The reaction was carried out at room temperature for 30 minutes and the absorbance at 405 nm was measured with a microplate reader. As a control group, a sample to which no sample was added was used.

표 4에서 확인할 수 있듯이, 자외선 조사시 발현이 유도되는 MMP-1에 대하여 실시예 2의 시료를 가하면 MMP-1 억제율이 증가되었고, 시료를 처리하지 않은 대조군에 비하여 75% 이상의 억제율을 보였다. As shown in Table 4, when the sample of Example 2 was added to MMP-1 in which expression was induced by ultraviolet irradiation, the MMP-1 inhibition rate was increased and the inhibition rate was over 75% as compared with the control without the sample.

이는 대조군으로 사용한 레티놀의 억제율에 비해 상당히 우수한 결과이다.This is an excellent result compared to the inhibition rate of retinol used as a control.

시험군Test group MMP-1 발현억제율 (%)MMP-1 expression inhibition rate (%) 음성 대조군Negative control group -- 실시예 2 (0.05중량%)Example 2 (0.05% by weight) 7575 실시예 2 (0.02중량%)Example 2 (0.02% by weight) 6060 실시예 2 (0.01중량%)Example 2 (0.01% by weight) 3131 레티놀Retinol 4141

실험예 5 : 자외선 조사에 의한 세포독성 완화 효과Experimental Example 5: Cytotoxicity mitigation effect by ultraviolet irradiation

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 자외선 조사에 의한 세포독성의 완화 효과를 평가하였다. The cytotoxic effect of the culture of the Lactobacillus coumarbatus J2K-01 strain obtained in Example 2 on UV irradiation was evaluated.

섬유아세포(fibroblast)를 24-웰 시험 플레이트에 1x105개씩 넣고 24시간 동안 부착시켰다. Fibroblasts were placed in 24-well test plates at 1 × 10 5 cells and adhered for 24 hours.

각 웰을 PBS로 1회 세척하고 각 웰에 500ul의 PBS를 넣었다. 이 섬유아세포에 자외선 B(UVB) 램프(Model: F15T8, UV B 15W, Sankyo Dennki사, Japan)를 이용하여 자외선 10mJ/㎠를 조사한 후 PBS를 덜어내고 세포배양 배지(DMEM에 10% FBS가 첨가된 것) 1㎖을 첨가하였다. Each well was washed once with PBS and 500 ul of PBS was added to each well. The cells were irradiated with 10 mJ / cm 2 of ultraviolet light using ultraviolet B (UVB) lamp (Model: F15T8, UVB 15W, Sankyo Dennki, Japan) 1 ml) was added.

여기에 평가하고자 하는 시료를 처리한 후 24시간 동안 배양하였다. Here, the sample to be evaluated was treated and cultured for 24 hours.

24시간이 지나면 배지를 제거하고, 각 웰 당 세포배양 배지 500㎕배지와 MTT 용액(2.5㎎/㎖) 60㎕를 넣은 후 2시간 동안 37℃ CO2배양기에서 배양하였다. After 24 hours, the medium was removed, and cell culture medium (500 μl) and MTT solution (2.5 mg / ml) (60 μl) were added to each well and incubated for 2 hours at 37 ° C in a CO2 incubator.

배지를 제거하고 이소프로판올-HCl(0.04N)을 500㎕씩 넣어주었다. The medium was removed and 500 μl of isopropanol-HCl (0.04 N) was added.

5분간 진탕하여 세포를 용해시키고 상등액 100㎕씩을 96-웰 시험 플레이트에 옮긴 후, 마이크로플레이트 판독기에서 565nm 흡광도를 측정하였다. The cells were shaken for 5 minutes to dissolve the cells, and 100 쨉 l of the supernatant was transferred to a 96-well test plate, and absorbance at 565 nm was measured in a microplate reader.

수학식 3과 같이 세포생존율(%)을 측정하고 자외선에 의한 세포독성 완화율은 수학식 4에 의하여 계산하였다.The cell viability (%) was measured as shown in Equation (3), and the cytotoxic mitigation rate by ultraviolet was calculated by Equation (4).

<수학식 3>&Quot; (3) &quot;

세포생존율(%) ={(St-Bo)/(Bt-Bo)}X 100Cell survival rate (%) = {(St-Bo) / (Bt-Bo)} X 100

Bo: 세포배양배지 만을 발색 반응한 웰의 565nm 흡광도,Bo: absorbance at 565 nm of the well in which only the cell culture medium was color-

Bt: 시료를 처리하지 않은 웰을 발색 반응한 웰의 565nm 흡광도,Bt: absorbance at 565 nm of a well that underwent chromogenic reaction in a well not treated with the sample,

St: 시료를 처리한 웰을 발색 반응한 웰의 565nm 흡광도.St: Absorbance at 565 nm of a well that underwent chromogenic reaction in a sample-treated well.

<수학식 4>&Quot; (4) &quot;

자외선에 의한 세포독성 완화율(%) =1-(St-Bo)/(Bt-Bo)X 100Cytotoxicity mitigation rate by ultraviolet ray (%) = 1- (St-Bo) / (Bt-Bo) X 100

Bo: 자외선 조사하지 않고 시료 처리하지 않은 웰의 세포 생존율,Bo: the cell survival rate of wells not irradiated with ultraviolet rays and not treated,

Bt: 자외선 조사하고 시료를 처리하지 않은 웰의 세포생존율,Bt: cell survival rate of wells irradiated with ultraviolet rays and not treated with samples,

St: 자외선 조사하고 시료를 처리한 웰의 세포생존율.St: Cell survival rate of well irradiated and treated samples.

시료 처리농도(%)Sample treatment concentration (%) 세포독성 완화율 (%)Cytotoxic Relaxation Rate (%) 실시예 2 (0.05중량%)Example 2 (0.05% by weight) 4747 실시예 2 (0.02중량%)Example 2 (0.02% by weight) 3131 실시예 2 (0.01중량%)Example 2 (0.01% by weight) 1515

표 5에서 확인할 수 있듯이, 실험 결과 실시예 2의 락토바실러스 쿠르바투스 J2K-01 균주의 배양물은 0.05% 농도에서 47%의 자외선에 의한 세포독성을 완화하여 자외선에 의한 세포독성을 효과적으로 방어함을 알 수 있었다.As shown in Table 5, the culture of the Lactobacillus carbamazep J2K-01 strain of Example 2 effectively inhibited cytotoxicity by ultraviolet light by mitigating cytotoxicity by 47% of ultraviolet rays at a concentration of 0.05% And it was found.

상기의 결과로부터 락토바실러스 쿠르바투스 J2K-01 균주의 배양물의 자외선에 의한 피부자극 완효 효과를 추론할 수 있다.From the above results, it is possible to deduce the skin irritation effect of the culture of Lactobacillus carbatus strain J2K-01 by ultraviolet rays.

실험예 6 : 타입 1 프로콜라겐 생합성 촉진 효과Experimental Example 6: Promotion of type 1 procollagen biosynthesis

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 첨가한 후 피부기질 성분인 타입 1 프로콜라겐의 생합성을 촉진시키는 효과를 알아보기 위하여 프로콜라겐 분석(procollagen assay)을 아래와 같은 방법으로 실시하였다.To investigate the effect of promoting the biosynthesis of type 1 procollagen, which is a skin matrix component, after the culture of the Lactobacillus coumarbatus J2K-01 strain obtained in Example 2, a procollagen assay was conducted under the following conditions The same method was used.

신생아의 포피조직에서 분리한 사람진피섬유아세포(human dermal fibroblast)는 Modern Tissue Technology(MTT, Korea)로부터 분양받아 DMEM/F-12(3:1)배지에 10% 우태아혈청(FBS)을 첨가하여 1× 104 cell/㎠ 농도로 배양하였다. Human dermal fibroblasts isolated from neonatal foreskin tissues were purchased from Modern Tissue Technology (MTT, Korea) and supplemented with 10% fetal bovine serum (FBS) in DMEM / F-12 (3: And cultured at a concentration of 1 × 10 4 cells / cm 2.

70-80% 정도 자라면 1:3의 비율로 분주하여 계대 배양하였고, 3~4차 계대배양된 세포를 실험에 이용하였다. When 70-80% of the cells were grown, the cells were subcultured at a ratio of 1: 3, and cells in the third to fourth subculture were used for the experiment.

프로콜라겐의 양을 측정하는 실험을 위해서 섬유아세포를 48 웰 플레이트(well plate)에 90% 이상 배양한 후 실시예 2 시료를 가하고, 24시간 후에 배지 중에 유리된 프로콜라겐의 양을 프로콜라겐타입-1C-펩타이드 EIA 키트(procollagen type-1 C-peptide EIA kit)(MK101, Takara, Japan)를 사용하여 측정하였다.For the experiment to measure the amount of procollagen, the fibroblasts were cultured in a 48-well plate at 90% or more, and then the sample of Example 2 was added. After 24 hours, the amount of procollagen liberated in the medium was measured using a procollagen- 1C-peptide EIA kit (MK101, Takara, Japan).

결과는 표 6에 나타냈으며, 실시예 2 시료를 0.05% 처리 시 프로콜라겐의 생합성이 58%를 촉진하였으며 이는 세포신호전달 물질인 TGF-β와 유사한 효과였다.The results are shown in Table 6. In the 0.05% treatment of the sample of Example 2, the biosynthesis of procollagen promoted 58%, which was similar to that of TGF-beta, a cell signaling substance.

시료명Name of sample 프로콜라겐 생합성촉진효과Promoting effect of procollagen biosynthesis 실시예 2 (0.05중량%)Example 2 (0.05% by weight) 5858 실시예 2 (0.02중량%)Example 2 (0.02% by weight) 3434 실시예 2 (0.01중량%)Example 2 (0.01% by weight) 2020 TGF-βTGF-beta 5555

실험예 7 : 피부 탄력 개선 효과 및 주름 개선Experimental Example 7: Skin elasticity improvement effect and wrinkle improvement

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 함유한 화장료를 제조하여 사람을 대상으로 비교예 1과 비교실험을 행하여 피부 탄력 개선 효과 및 주름 개선 효과를 평가하였다.A cosmetic preparation containing the culture of the Lactobacillus carbamazep J2K-01 strain obtained in Example 2 was prepared and compared with Comparative Example 1 to humans, and skin elasticity improving effect and wrinkle improving effect were evaluated.

비교실험에 사용된 화장료는 크림형태이고, 하기 표 7에 기재된 조성에 따라 통상적인 방법으로 크림(실시예 3, 비교예 1)을 제조하였다. The cosmetics used in the comparative experiments were in the form of a cream, and cream (Example 3, Comparative Example 1) was prepared according to the composition shown in Table 7 below in a conventional manner.

실험자(20세-35세의 여성) 20명을 대상으로 얼굴 오른쪽 부위에는 실시예 3에서 제조된 크림을, 얼굴 왼쪽 부위에는 비교예 1에서 제조된 크림을 각각 1일 2회씩 연속 2개월간 도포하였다.The cream prepared in Example 3 was applied to the right side of the face and the cream prepared in Comparative Example 1 was applied to the left side of the face for two consecutive months for 20 consecutive months for 20 subjects (20 to 35 year old female) .

실험완료 후 피부 탄력 개선 효과는 제품 사용 전과 2개월간 사용 후에 피부탄력측정기(cutometer SEM 575, C+K Electronic Co., Germany)를 이용하여 측정하였다. The skin elasticity was measured by using a skin elasticity meter (SEM 575, C + K Electronic Co., Germany) before and after using the product for 2 months.

실험결과는 하기 표 8에 Cutometer SEM 575의 △R7 값으로 기재하였는데 R7 값은 피부의 점탄성(viscoelasticity)을 나타낸다. 표 8와 같이 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 함유한 크림을 도포한 실험자의 피부 탄력개선 효과가 우수함을 알 수 있다.The experimental results are shown in the following Table 8 as the ΔR7 value of Cutometer SEM 575, where the R7 value represents the viscoelasticity of the skin. As shown in Table 8, it can be seen that the skin elasticity improving effect of the experimenter coated with the cream containing the culture of Lactobacillus carbatus strain J2K-01 is excellent.

원료Raw material 실시예 3Example 3 비교예 1Comparative Example 1 정제수Purified water 잔량Balance 잔량Balance 글리세린glycerin 88 88 베타글루칸Beta Glucan 55 55 카보머Carbomer 0.10.1 0.10.1 스테아린산 콜레스테롤Stearic acid cholesterol 22 22 스쿠알란Squalane 44 44 세테아릴 알코올Cetearyl alcohol 66 66 폴리옥시에틸렌알콜에스테르Polyoxyethylene alcohol ester 33 33 카프릴릭/카프릭 트리글리세라이드Caprylic / capric triglyceride 88 88 실시예 2Example 2 1One -- 프로필렌글리콜Propylene glycol 55 55 incense 적량Suitable amount 적량Suitable amount 색소Pigment 적량Suitable amount 적량Suitable amount 방부제antiseptic 적량Suitable amount 적량Suitable amount 합계Sum 100100 100100

주)단위: 중량%Note) Unit: wt%

실험제품Experimental product 피부탄력효과(△R7)Skin elasticity effect (△ R7) 실시예 3Example 3 0.320.32 비교예 1Comparative Example 1 0.110.11

n=20, p<0.05n = 20, p < 0.05

실험자(20세-35세의 여성) 20명을 대상으로 얼굴 오른쪽 부위에는 실시예 3에서 제조된 크림을, 얼굴 왼쪽 부위에는 비교예 1에서 제조된 크림을 각각 1일 2회씩 연속 2개월간 도포하였다.The cream prepared in Example 3 was applied to the right side of the face and the cream prepared in Comparative Example 1 was applied to the left side of the face for two consecutive months for 20 consecutive months for 20 subjects (20 to 35 year old female) .

실험완료 후 피부 주름 개선 효과는 제품 사용 전과 2개월간 사용 후에 피부의 주름개선효과를 알아보기 위하여 실리콘 재질의 모사판(replica)을 제작하여 지정 부위의 주름의 상태를 화상분석기인 비지오미터(visiometer: SV60, C+K Electronic Co., Germany)로 측정하였다. To evaluate the wrinkle improvement effect of the skin before and after the use of the product after the completion of the experiment, a silicone replica was made and the wrinkle state of the designated area was measured with a visiometer SV60, C + K Electronic Co., Germany).

그 결과를 하기 표 9에서 나타내었으며, 이 결과는 2개월 후의 각각의 파라미터(parameter) 값에서 2개월 전 파라미터 값을 뺀 것의 평균을 나타낸 것이다.The results are shown in Table 9, which shows the average value of each parameter after 2 months minus the parameter value two months ago.

즉, 이 값이 음수가 나올수록 주름 개선 효과가 높다는 것을 의미한다.That is, the negative value indicates that the wrinkle improving effect is higher.

따라서 표 9에서 나타나듯 실시예 2의 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 함유한 실시예 3의 피부 주름 개선 효과가 크게 증진되었음을 확인할 수 있었다.Therefore, as shown in Table 9, it was confirmed that the effect of improving the wrinkles of the skin of Example 3 containing the culture of Lactobacillus coumarbatus J2K-01 strain of Example 2 was greatly enhanced.

실험제품Experimental product R1R1 R2R2 R3R3 R4R4 R5R5 실시예 3Example 3 -0.21-0.21 -0.15-0.15 -0.11-0.11 -0.08-0.08 -0.09-0.09 비교예 1Comparative Example 1 -0.11-0.11 -0.06-0.06 -0.05-0.05 -0.04-0.04 -0.02-0.02 R1: 주름 등고선의최고치와 최저치의 차이값
R2: 주름 등고선을 임의로 5칸씩 나눈 후 그 중 R1값 들의 평균
R3: 5개씩 나눈 R1값 중 최고치
R4: 주름 등고선의 기선(baseline)에서 각각의 꼭대기와 계곡의 값을 뺀 평균값
R5: 주름 등고선의 기선에서 각각의 주름 윤곽을 뺀 값의 평균값
R1: Difference between the maximum value and the minimum value of the wrinkle contour line
R2: The wrinkle contour line is arbitrarily divided into 5 squares, and the average of R1 values
R3: Maximum value of R1 divided by 5
R4: Mean value of the baseline of the wrinkle contour minus the value of each apex and valley
R5: Mean value of the value obtained by subtracting the outline of each wrinkle from the base line of the wrinkle contour line

실험예 8 : 피부자극 완화 효과Experimental Example 8: Effect of skin irritation mitigation

상기 실시예 2에서 수득한 락토바실러스 쿠르바투스 J2K-01 균주의 배양물을 함유한 화장료의 자극 완화 효과를 인체 첩포 시험으로 평가하였다.The effect of stimuli relaxation of the cosmetic containing the culture of the Lactobacillus carbapthus strain J2K-01 obtained in Example 2 was evaluated by a human skin patch test.

일반적 화장품 처방(크림, 로션, 스킨, 에센스)에 자극을 일으키는 SLS(Sodium lauryl sulfate) 1%와 실시예 3에서 제조된 제품을 혼용하여 24시간, 48시간, 72시간 동안 첩포하여 자극 유발지수를 바탕으로 자극완화 효과를 평가한 것이다.1% of sodium lauryl sulfate (SLS), which stimulates general cosmetic prescriptions (cream, lotion, skin, essence), and the product prepared in Example 3 were mixed for 24 hours, 48 hours and 72 hours, And the effect of stimulation relaxation was evaluated.

20-50세의 건강한 남녀 50명의 팔 상박 부위에 FINN CHAMBER(FINLAND)를 이용하여 각각의 제품을 0.3 mg씩 첩포하고, 24시간 후 급성 자극 지수를 평가하였다. Each product was sprayed with 0.3 mg of FINN CHAMBER (FINLAND) on the upper arm of 50 healthy men and women aged 20 to 50 years, and the acute irritation index was evaluated after 24 hours.

평가 후 재차 동일한 부위에 동량의 제품을 첩포하여 48시간 및 72시간 후의 지연성 자극 지수를 평가하였다.After the evaluation, the same amount of the product was applied again to the same site again to evaluate the delayed irritation index after 48 hours and 72 hours.

시험 결과 SLS를 단독으로 첩포한 부분은 24시간 후부터 피부에 붉게 자극이 나타났으나, 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유하는 제품을 첩포한 경우에는 24시간, 48시간, 72시간 경과 후에도 아무런 피부 발작을 일으키지 않았다.As a result of the test, when the product containing the Lactobacillus carbamazep J2K-01 culture of the present invention was applied on the skin, There was no skin attack after 72 hours.

이 결과는 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물이 화장료에 혼용되었을 때 자극을 유발시키는 기재(계면 활성제, 향, 알콜)에 의한 피부 자극을 감소시킬 수 있는 유의한 효과가 있음을 나타내는 것이다.This result shows that there is a significant effect of reducing skin irritation caused by a stimulant (surfactant, fragrance, alcohol) when the Lactobacillus carbatis J2K-01 culture of the present invention is mixed with cosmetics .

이하에 그 외의 실시예를 나타내었다. Other examples are shown below.

즉, 실시예 2에서 수득한 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유한 샴푸, 화장수, 유액 및 미용액을 실시예 4 내지 7와 같이 제조하였다.That is, the shampoo, lotion, milky lotion and serum of the present invention obtained in Example 2 containing the lactobacillus carbamazu J2K-01 culture of the present invention were prepared as in Examples 4 to 7.

이들 본 발명의 락토바실러스 쿠르바투스 J2K-01(기탁번호: KCTC 13494BP) 배양물을 함유한 샴푸, 화장수, 유액 및 미용액은 활성산소 소거효과와 콜라겐 분해효소 활성 조절효과, 피부 잔주름 개선 효과, 피부 탄력 개선 효과, 피부자극 완화효과 등 피부개선에 우수한 효과를 나타내었다. The shampoos, lotions, emulsions and cosmetic liquids containing the cultures of Lactobacillus carbamazep J2K-01 (Accession No .: KCTC 13494BP) of the present invention have a reactive oxygen scavenging effect and a collagenase activity controlling effect, The effect of improving elasticity, the effect of alleviating skin irritation, and the like.

실시예 4 : 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유하는 샴푸 제조Example 4: Production of Shampoo Containing Culture of Lactobacillus Carbatus J2K-01 of the Present Invention

95% 에탄올 5g에 암모늄라우레스설페이트 5g, 코실베타인 5g, 알킬에테르셀페이트 0.5g, 실리콘 0.5g, 폴리쿼터 0.2g, 향료 0.2g, 보존제 0.02g를 혼합하였다. 실시예 2에서 수득한 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물 5g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 샴푸를 얻었다.To 5 g of 95% ethanol, 5 g of ammonium laureth sulfate, 5 g of cosyl betaine, 0.5 g of alkyl ether cellate, 0.5 g of silicone, 0.2 g of polyquater, 0.2 g of fragrance and 0.02 g of preservative were mixed. 5 g of the lactobacillus carbamazep J2K-01 culture of the present invention obtained in Example 2 and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added to the mixture, followed by stirring to obtain a shampoo.

실시예 5 : 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유하는 화장수 제조Example 5 Production of Cosmetic Lotion Containing Culture of Lactobacillus Carbatus J2K-01 of the Present Invention

95% 에탄올 8g에 폴리피로리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합하였다. 0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of perfume, 0.1 g of p-hydroxybenzoic acid methyl ester, a small amount of antioxidant and a small amount of dye were mixed in 8 g of 95% ethanol.

실시예 2에서 수득한 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물 10g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 화장수를 얻었다.10 g of the lactobacillus carbamazu J2K-01 culture of the present invention obtained in Example 2 and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added to the mixture, followed by stirring to obtain a lotion.

실시예 6 : 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유한 유액 제조Example 6: Preparation of an emulsion containing the lactobacillus carbatous J2K-01 culture of the present invention

세틸알콜1.2g, 스쿠알란 10g, 바세린 2g, 파라옥시안식향산에틸에스테르 0.2g, 글리세린모노에스테아레이드 1g, 폴리옥시에틸렌(20몰 부가)모노올레이트 1g및 향로 0.1g을 70℃에서 가열 및 혼합하여 용해하고, 실시예 2에서 수득한 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물 0.5g, 디프로필렌글리콜 5g, 폴리에틸렌글리콜-1500 2g, 트리에탄올아민 0.2g, 정제수 76.2g을 75℃로 가열해서 용해하였다. 양자를 혼합하여 유화시킨 후 냉각하여 수중유(O/W)형의 유액을 얻었다.0.2 g of cetyl alcohol, 10 g of squalane, 2 g of vaseline, 0.2 g of p-hydroxybenzoic acid ethyl ester, 1 g of glycerin monoestearylate, 1 g of polyoxyethylene (20 mol addition) monooleate and 0.1 g of coryneform were heated and mixed at 70 캜 , 0.5 g of the lactobacillus carbamazu J2K-01 culture of the present invention obtained in Example 2, 5 g of dipropylene glycol, 2 g of polyethylene glycol-1,500, 0.2 g of triethanolamine and 76.2 g of purified water were heated to 75 캜 Lt; / RTI &gt; The two were mixed and emulsified and then cooled to obtain oil-in-water (O / W) type emulsion.

실시예 7 : 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물을 함유한 미용액 제조Example 7: Preparation of serum of the present invention containing a culture of Lactobacillus carbamazu J2K-01

95% 에틸알콜 5g에 폴리옥시에틸렌솔비탄모노올레이트 1.2g, 키툴로오즈 0.3g, 히아루론산나트륨 0.2g, 비타민 E-아세테이트 0.2g, 감초산 나트륨 0.2g, 파라옥시안식향산에틸에스테르 0.1g, 실시예 2에서 수득한 본 발명의 락토바실러스 쿠르바투스 J2K-01 배양물 1g 및 적량의 색소를 혼합하여 미용액을 얻었다.To 5 g of 95% ethyl alcohol, 1.2 g of polyoxyethylene sorbitan monooleate, 0.3 g of chitoolose, 0.2 g of sodium hyaluronate, 0.2 g of vitamin E-acetate, 0.2 g of sodium permanganate, 0.1 g of p-hydroxybenzoic acid ethyl ester 1 g of the lactobacillus carbamazu J2K-01 culture of the present invention obtained in Example 2 and an appropriate amount of pigment were mixed to obtain a serum.

한국생명공학연구원Korea Biotechnology Research Institute KCTC13494BPKCTC13494BP 2018031420180314

<110> J2KBIO CO., LTD. <120> LACTOBACILLUS CURVATUS J2K-01 STRAIN AND A COSMETIC COMPOSITION USING THE SAME FROM KIMCHI <130> j2k-01 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1521 <212> RNA <213> Lactobacillus curvatus <400> 1 ctcaggacga acgctggcgg cgtgcctaat acatgcaagt cgaacgcact ctcgttagat 60 tgaagaagct tgcttctgat tgataacatt tgagtgagtg gcggacgggt gagtaacacg 120 tgggtaacct gccctaaagt gggggataac atttggaaac agatgctaat accgcataaa 180 acctagcacc gcatggtgca aggttgaaag atggtttcgg ctatcacttt aggatggacc 240 cgcggtgcat tagttagttg gtgaggtaaa ggctcaccaa gaccgtgatg catagccgac 300 ctgagagggt aatcggccac actgggactg agacacggcc cagactccta cgggaggcag 360 cagtagggaa tcttccacaa tggacgaaag tctgatggag caacgccgcg tgagtgaaga 420 aggttttcgg atcgtaaaac tctgttgttg gagaagaacg tatttgatag taactgatca 480 ggtagtgacg gtatccaacc agaaagccac ggctaactac gtgccagcag ccgcggtaat 540 acgtaggtgg caagcgttgt ccggatttat tgggcgtaaa gcgagcgcag gcggtttctt 600 aagtctgatg tgaaagcctt cggctcaacc gaagaagtgc atcggaaact gggaaacttg 660 agtgcagaag aggacagtgg aactccatgt gtagcggtga aatgcgtaga tatatggaag 720 aacaccagtg gcgaaggcgg ctgtctggtc tgtaactgac gctgaggctc gaaagcatgg 780 gtagcaaaca ggattagata ccctggtagt ccatgccgta aacgatgagt gctaggtgtt 840 ggagggtttc cgcccttcag tgccgcagct aacgcattaa gcactccgcc tggggagtac 900 gaccgcaagg ttgaaactca aaggaattga cgggggcccg cacaagcggt ggagcatgtg 960 gtttaattcg aagcaacgcg aagaacctta ccaggtcttg acatcctttg accactctag 1020 agatagagct ttcccttcgg ggacaaagtg acaggtggtg catggttgtc gtcagctcgt 1080 gtcgtgagat gttgggttaa gtcccgcaac gagcgcaacc cttattacta gttgccagca 1140 tttagttggg cactctagtg agactgccgg tgacaaaccg gaggaaggtg gggacgacgt 1200 caaatcatca tgccccttat gacctgggct acacacgtgc tacaatggat ggtacaacga 1260 gtcgcgagac cgcgaggttt agctaatctc ttaaaaccat tctcagttcg gattgtaggc 1320 tgcaactcgc ctacatgaag ccggaatcgc tagtaatcgc ggatcagcat gccgcggtga 1380 atacgttccc gggccttgta cacaccgccc gtcacaccat gagagtttgt aacacccaaa 1440 gccggtgagg taaccttcgg gagccagccg tctaaggtgg gacagatgat tagggtgaag 1500 tcgtaacagg gtaacccgta a 1521 <110> J2KBIO CO., LTD. <120> LACTOBACILLUS CURVATUS J2K-01 STRAIN AND A COSMETIC COMPOSITION          USING THE SAME FROM KIMCHI <130> j2k-01 <160> 1 <170> KoPatentin 3.0 <210> 1 <211> 1521 <212> RNA <213> Lactobacillus curvatus <400> 1 ctcaggacga acgctggcgg cgtgcctaat acatgcaagt cgaacgcact ctcgttagat 60 tgaagaagct tgcttctgat tgataacatt tgagtgagtg gcggacgggt gagtaacacg 120 tgggtaacct gccctaaagt gggggataac atttggaaac agatgctaat accgcataaa 180 acctagcacc gcatggtgca aggttgaaag atggtttcgg ctatcacttt aggatggacc 240 cgcggtgcat tagttagttg gtgaggtaaa ggctcaccaa gaccgtgatg catagccgac 300 ctgagagggt aatcggccac actgggactg agacacggcc cagactccta cgggaggcag 360 cagtagggaa tcttccacaa tggacgaaag tctgatggag caacgccgcg tgagtgaaga 420 aggttttcgg atcgtaaaac tctgttgttg gagaagaacg tatttgatag taactgatca 480 ggtagtgacg gtatccaacc agaaagccac ggctaactac gtgccagcag ccgcggtaat 540 acgtaggtgg caagcgttgt ccggatttat tgggcgtaaa gcgagcgcag gcggtttctt 600 aagtctgatg tgaaagcctt cggctcaacc gaagaagtgc atcggaaact gggaaacttg 660 agtgcagaag aggacagtgg aactccatgt gtagcggtga aatgcgtaga tatatggaag 720 aacaccagtg gcgaaggcgg ctgtctggtc tgtaactgac gctgaggctc gaaagcatgg 780 gtagcaaaca ggattagata ccctggtagt ccatgccgta aacgatgagt gctaggtgtt 840 ggagggtttc cgcccttcag tgccgcagct aacgcattaa gcactccgcc tggggagtac 900 gaccgcaagg ttgaaactca aaggaattga cgggggcccg cacaagcggt ggagcatgtg 960 gtttaattcg aagcaacgcg aagaacctta ccaggtcttg acatcctttg accactctag 1020 agatagagct ttcccttcgg ggacaaagtg acaggtggtg catggttgtc gtcagctcgt 1080 gtcgtgagat gttgggttaa gtcccgcaac gagcgcaacc cttattacta gttgccagca 1140 tttagttggg cactctagtg agactgccgg tgacaaaccg gaggaaggtg gggacgacgt 1200 caaatcatca tgccccttat gacctgggct acacacgtgc tacaatggat ggtacaacga 1260 gtcgcgagac cgcgaggttt agctaatctc ttaaaaccat tctcagttcg gattgtaggc 1320 tgcaactcgc ctacatgaag ccggaatcgc tagtaatcgc ggatcagcat gccgcggtga 1380 atacgttccc gggccttgta cacaccgccc gtcacaccat gagagtttgt aacacccaaa 1440 gccggtgagg taaccttcgg gagccagccg tctaaggtgg gacagatgat tagggtgaag 1500 tcgtaacagg gtaacccgta a 1521

Claims (7)

피부 탄력 및 주름개선용 화장료 조성물에 있어서,
균주 배양물 1 중량%와, 글리세린 8 중량%와, 베타글루칸 5 중량%와, 카보머 0.1 중량%와, 스테아린산 콜레스테롤 2 중량%와, 스쿠알란 4 중량%와, 세테아릴 알코올 6 중량%와, 폴리옥시에틸렌알콜에스테르 3 중량%와, 카프릴릭/카프릭 트리글리세라이드 8 중량%와, 프로필렌글리콜 5 중량%를 포함하여 구성되며,
상기 균주 배양물은,
기탁번호 KCTC 13494BP로 부여된, 묵은 김치로부터 분리한 락토바실러스 쿠르바투스(Lactobacillus curvatus) J2K-01 균주를 배지에 접종하여 배양하여 제조하되,
배양액의 pH를 5.5로 조정하고, 배양 시간은 24시간, 배양 온도는 35℃로 하며,
배양 배지의 탄소원으로서 글루코스를 배지 총부피 대비 2%(W/V) 포함시키고,
배양 배지의 질소원으로서 효모추출물을 배지 총부피 대비 1%(W/V) 포함시키며,
배양 배지의 미량원소원으로서 황산망간을 배지 총부피 대비 0.1%(W/V), 포함시키고, 황산마그네슘을 배지 총부피 대비 0.05%(W/V) 포함시키며, 염화칼슘을 배지 총부피 대비 0.025%(W/V) 포함시키는 조건으로 배양하며,
배양 후 원심분리하여 배양액으로부터 균체를 제거하고 상등액을 여과하여 수득한 것을 특징으로 하는,
피부 탄력 및 주름개선용 화장료 조성물.
A cosmetic composition for improving skin elasticity and wrinkles,
1% by weight of strain culture, 8% by weight of glycerin, 5% by weight of betaglucan, 0.1% by weight of carbomer, 2% by weight of stearic acid cholesterol, 4% by weight squalane, 6% by weight of cetearyl alcohol, 3% by weight of polyoxyethylene alcohol ester, 8% by weight of caprylic / capric triglyceride and 5% by weight of propylene glycol,
The culture of the strain may contain,
The Lactobacillus curvatus strain J2K-01 isolated from the old kimchi, which is assigned to deposit number KCTC 13494BP, is inoculated into the medium and cultured,
The pH of the culture was adjusted to 5.5, the incubation time was 24 hours, the incubation temperature was 35 ° C,
As a carbon source of the culture medium, glucose was contained in an amount of 2% (W / V) based on the volume of the culture medium,
As the nitrogen source of the culture medium, the yeast extract contained 1% (W / V) of the total volume of the culture medium,
Manganese sulfate was added to the culture medium as a trace element source in an amount of 0.1% (W / V) relative to the total volume of the culture medium. Magnesium sulfate was contained in an amount of 0.05% (W / V) (W / V)
Culturing, centrifuging to remove cells from the culture, and filtering the supernatant.
A cosmetic composition for skin elasticity and wrinkle improvement.
삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete
KR1020180113419A 2018-09-21 2018-09-21 A cosmetic composition KR101930342B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180113419A KR101930342B1 (en) 2018-09-21 2018-09-21 A cosmetic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180113419A KR101930342B1 (en) 2018-09-21 2018-09-21 A cosmetic composition

Publications (1)

Publication Number Publication Date
KR101930342B1 true KR101930342B1 (en) 2018-12-19

Family

ID=65009256

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180113419A KR101930342B1 (en) 2018-09-21 2018-09-21 A cosmetic composition

Country Status (1)

Country Link
KR (1) KR101930342B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102167786B1 (en) * 2020-07-28 2020-10-19 주식회사 토리든 manufacturing method of fermented extract of Centella asiatica, Althaea rosea, Blue lotus, Swertia japonica Griseb using Lactobacillus and cosmetic composition using that fermented extract
KR102244492B1 (en) * 2020-10-21 2021-04-26 대한민국(관리부서:국립수산과학원) A novel Lactobacillus sp. strain and use thereof
KR20210062350A (en) * 2019-11-21 2021-05-31 애경산업(주) Cosmetic composition for improving skin troubles due to fine dust

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101134324B1 (en) 2011-10-07 2012-04-13 나윤경 Media of powder for mass culture of microorganism
JP2014516524A (en) 2011-05-12 2014-07-17 プロバイオニック カンパニー リミテッド Antibacterial antiviral rice lactic acid bacteria fermented food composition containing an active ingredient of rice saccharified liquid fermented with kimchi lactic acid bacteria
KR101838281B1 (en) 2016-12-12 2018-03-14 한국식품연구원 Lactobacillus curvatus WIKIM53 having anti-allergic disease activity and composition for comprising the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014516524A (en) 2011-05-12 2014-07-17 プロバイオニック カンパニー リミテッド Antibacterial antiviral rice lactic acid bacteria fermented food composition containing an active ingredient of rice saccharified liquid fermented with kimchi lactic acid bacteria
KR101134324B1 (en) 2011-10-07 2012-04-13 나윤경 Media of powder for mass culture of microorganism
KR101838281B1 (en) 2016-12-12 2018-03-14 한국식품연구원 Lactobacillus curvatus WIKIM53 having anti-allergic disease activity and composition for comprising the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, Epub. ahead of print, pp.1-11(Epub.2018.02.27.)*

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210062350A (en) * 2019-11-21 2021-05-31 애경산업(주) Cosmetic composition for improving skin troubles due to fine dust
KR102349188B1 (en) * 2019-11-21 2022-01-10 애경산업(주) Cosmetic composition for improving skin troubles due to fine dust
KR102167786B1 (en) * 2020-07-28 2020-10-19 주식회사 토리든 manufacturing method of fermented extract of Centella asiatica, Althaea rosea, Blue lotus, Swertia japonica Griseb using Lactobacillus and cosmetic composition using that fermented extract
KR102244492B1 (en) * 2020-10-21 2021-04-26 대한민국(관리부서:국립수산과학원) A novel Lactobacillus sp. strain and use thereof

Similar Documents

Publication Publication Date Title
KR100964018B1 (en) A method for producing extract of fermented fucoxanthin and Cosmetic composition containing thereof
KR102125316B1 (en) cosmetic composition for anti-irritation and skin soothing using Lactobacillus pentosus J2K-185strain
KR101930342B1 (en) A cosmetic composition
KR102145447B1 (en) Cosmetic compositions containing fermented extract of Hippophae rhamnoides L
KR102073013B1 (en) A cosmetic composion for anti-stress effect and skin soothing effect
KR101814498B1 (en) Cosmetic Composition Containing the Mixed Extract of Eucalyptus Globulus Leaf and Trifolium Pratense Leaf
KR20120140141A (en) Cosmetic composition comprising the fermented extracts and the extracts of the rice
KR100898311B1 (en) Cosmetic composition containing extract of mixed fermentation with soy bean milk
KR101855206B1 (en) Cosmetic Composition Comprising the Fermented Extract of Panax ginseng
KR101960810B1 (en) Cosmetic Composition Containing the Mixed Extract of Black Currant Fruit and Aronia Melanocarpa Fruit
KR101931654B1 (en) Method for preparing extract of fermented silkworm cocoon for antioxdidation and skin-whitening, and a cosmetic composition containing fermented extract of silkworm cocoon as an active ingredients
KR20160096272A (en) A skin-care agent containing Mesembryanthemum crystallinum L. fermentation extract using yeast
KR101803757B1 (en) Cosmetic composition containing natural complex fermented extracts
KR20190064306A (en) Cosmetic composition comprising functional peptides and fermented products
KR102139000B1 (en) Antioxidant, anti-wrinkle, whitening and antibiotic cosmetic composition comprising fermented Methyl Sulfonyl methane extract and the preparation method of the same
KR20190048935A (en) Cosmetic composition comprising extract of red onion fermented by aureobasidium pullulans
KR20080046830A (en) Cosmetic composition containing fermented black allium sativum
KR101911442B1 (en) A novel Bacillus jejuensis HB-20 strain and a cosmetic composition using the same
KR20110116389A (en) A skin-care agent containing fermented aloe and gastrodia elata
KR20110122448A (en) Cosmetic composition comprising the extract of filipendula formosa as active ingredient
KR101244101B1 (en) Cosmetic composition for improving skin inflammation and including a fermented product of paprika as an effective ingredient
KR20150139679A (en) Cosmetic compositions of Chinese herb medicines extract ferment for soybean fermented liquor
KR102453319B1 (en) Fermented extract for antioxidant, anti-inflammatory, whitening, and anti-wrinkle using Lactobacillus kunkeei Hankook-001strain, and manufacturing method of it, and cosmetic composition containing fermented extract
KR101810825B1 (en) Cosmetics compositions containing fermentation extract from leaf Daphniphyllum macropodum Miq.
KR101966184B1 (en) NTI-FUNGAL Cosmetic Composition of Malassezia furfur

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant